Arena withdrawing obesity drug regulatory application in Europe (Bloomberg, 2 May 2013)

13 May 2013


Arena Pharmaceuticals has announced a decision to review the marketing application made to the European Medicines Agency for its weight loss drug Belviq.

Full article


Share this story